ClinicalTrials.Veeva

Menu

Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease

V

Vakif Gureba Training and Research Hospital

Status

Completed

Conditions

Hashimoto Disease

Study type

Observational

Funder types

Other

Identifiers

NCT01102205
tastoshashi

Details and patient eligibility

About

Oxidative stress leads to or accompanies with numerous disease. Oxidative balance in subclinical hypothyroid or euthyroid state in Hashimoto disease are not known. Effect of levothyroxine therapy on oxidative balance are also not known in hashimoto disease.

Full description

oxidative stress markers will be measured initially(TAS,TOS,OSI,PARAOXONASE,ARYLESTERASA,PON1 PHENOTYPİNG,LİPİDPEROXİD).After 3 months therapy with levothyroxine measurements will be repeated except PON1 phenotyping.

Enrollment

130 patients

Sex

All

Ages

18 to 95 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age more than 18 years

Exclusion criteria

  • inability to give a written consent
  • other conditions and drug usage affect oxidative stress

Trial design

130 participants in 3 patient groups

healthy
euthyroid hashimoto
hypothyroid hashimoto

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems